微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 81.94% | 1.36% | 3.26% | 4/140 | 52.37% | 迈克生物 | 57.29% | 行业排名> |
| 2025-12-31 | 79.35% | 1.08% | -0.64% | 5/140 | 51.9% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-09-30 | 79.86% | 2.64% | 0.34% | 5/140 | 52.23% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-06-30 | 79.59% | 2.93% | -1.55% | 7/140 | 52.43% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-03-31 | 80.84% | 5.18% | 2.98% | 5/140 | 52.13% | 佰仁医疗 | 88.54% | 行业排名> |
| 2024-12-31 | 78.5% | 5.14% | 0.88% | 10/140 | 53.08% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-09-30 | 77.81% | 2.92% | 0.62% | 10/140 | 53.87% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-06-30 | 77.33% | 3.69% | 0.61% | 10/140 | 53.95% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-03-31 | 76.86% | 3.02% | 2.94% | 14/140 | 53.88% | 佰仁医疗 | 89.27% | 行业排名> |
| 2023-12-31 | 74.66% | 0.1% | -1.24% | 18/140 | 53.57% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-09-30 | 75.6% | 2.1% | 1.37% | 16/140 | 54.44% | 正海生物 | 89.9% | 行业排名> |
| 2023-06-30 | 74.58% | 2.52% | -0.04% | 17/140 | 53.81% | 正海生物 | 90.39% | 行业排名> |
| 2023-03-31 | 74.61% | 5.57% | 0.03% | 18/140 | 54.06% | 正海生物 | 90.3% | 行业排名> |
| 2022-12-31 | 74.59% | 3.5% | 0.73% | 19/140 | 54.01% | 万泰生物 | 91.61% | 行业排名> |
| 2022-09-30 | 74.05% | 2.95% | 1.8% | 20/140 | 55.7% | 三友医疗 | 90.18% | 行业排名> |
| 2022-06-30 | 72.74% | 2.39% | 2.93% | 23/140 | 55.37% | 三友医疗 | 90.14% | 行业排名> |
| 2022-03-31 | 70.67% | 0.9% | -1.94% | 29/140 | 56.89% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 72.07% | 17.19% | 0.19% | 32/140 | 57.98% | 三友医疗 | 90.73% | 行业排名> |
| 2021-09-30 | 71.93% | 18.64% | 1.25% | 28/140 | 59.77% | 三友医疗 | 90.5% | 行业排名> |
| 2021-06-30 | 71.05% | 23.35% | 1.44% | 35/140 | 59.05% | 三友医疗 | 90.29% | 行业排名> |
| 2021-03-31 | 70.04% | 14.68% | 13.9% | 35/140 | 61.5% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 61.49% | -10.59% | 1.42% | 65/140 | 60.12% | 正海生物 | 91.59% | 行业排名> |
| 2020-09-30 | 60.63% | -11.23% | 5.26% | 50/140 | 62.21% | 正海生物 | 92.23% | 行业排名> |
| 2020-06-30 | 57.6% | -17.3% | -5.69% | 67/140 | 60.36% | 正海生物 | 92.69% | 行业排名> |
| 2020-03-31 | 61.07% | -11.74% | -11.2% | 39/140 | 58.8% | 正海生物 | 92.61% | 行业排名> |
| 2019-12-31 | 68.77% | 0.09% | 0.7% | 37/140 | 56.96% | 正海生物 | 94.38% | 行业排名> |
| 2019-09-30 | 68.3% | -0.87% | -1.94% | 21/140 | 55.83% | 正海生物 | 93.12% | 行业排名> |
| 2019-06-30 | 69.65% | 2.49% | 0.66% | 24/140 | 57.93% | 正海生物 | 93.78% | 行业排名> |
| 2019-03-31 | 69.2% | 0.36% | 0.71% | 16/140 | 52.61% | 正海生物 | 93.09% | 行业排名> |
| 2018-12-31 | 68.71% | -4.62% | -0.27% | 37/140 | 56.22% | 正海生物 | 93.85% | 行业排名> |
| 2018-09-30 | 68.9% | -5.59% | 1.38% | 16/140 | 52.76% | 正海生物 | 93.08% | 行业排名> |
| 2018-06-30 | 67.96% | -8.11% | -1.44% | 21/140 | 53.06% | 正海生物 | 92.83% | 行业排名> |
| 2018-03-31 | 68.95% | -7.13% | -4.29% | 14/140 | 52.55% | 正海生物 | 92.44% | 行业排名> |
| 2017-12-31 | 72.04% | 5.24% | -1.28% | 29/140 | 56.1% | 正海生物 | 92.7% | 行业排名> |
| 2017-09-30 | 72.98% | 9.37% | -1.33% | 12/140 | 53.53% | 正海生物 | 93.67% | 行业排名> |
| 2017-06-30 | 73.96% | 4.25% | -0.39% | 14/140 | 54.85% | 正海生物 | 94.14% | 行业排名> |
| 2017-03-31 | 74.25% | 6.05% | 8.46% | 8/140 | 54.29% | 正海生物 | 93.83% | 行业排名> |
| 2016-12-31 | 68.46% | -5.1% | 2.59% | 30/140 | 57.35% | 正海生物 | 93.69% | 行业排名> |
| 2016-09-30 | 66.73% | -7.19% | -5.94% | 9/140 | 51.85% | 正海生物 | 92.79% | 行业排名> |
| 2016-06-30 | 70.94% | 0.21% | 1.33% | 13/140 | 52.6% | 健帆生物 | 84.23% | 行业排名> |
| 2016-03-31 | 70.01% | -3.89% | -2.95% | 6/140 | 50.24% | *ST明德 | 86.71% | 行业排名> |